Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Grace Cullen
Phase 2 Study Evaluating the Combination of Sorafenib and Temsirolimus in the Treatment of Radioactive Iodine-Refractory Thyroid Cancer
Cancer
Cancer Research
Oncology
Related publications
Cost-Effectiveness of Sorafenib for Treatment of Radioactive Iodine (Rai)-Refractory Locally Advanced/Metastatic Differentiated Thyroid Cancer (Dtc) in Turkey
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Impact of Thyroid Cancer and Post-Surgical Radioactive Iodine Treatment on the Lives of Thyroid Cancer Survivors: A Qualitative Study
PLoS ONE
Multidisciplinary
Estimating the Economic Impact of Sorafenib in Treatment of Locally Recurrent or Metastatic, Progressive, Differentiated Thyroid Carcinoma (DTC) That Is Refractory to Radioactive Iodine (RAI) Treatment
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
RECIST 1.1 and Serum Thyroglobulin Measurements in the Evaluation of Responses to Sorafenib in Patients With Radioactive Iodine‑refractory Differentiated Thyroid Carcinoma
Oncology Letters
Cancer Research
Oncology
Targetable Gene Fusions Identified in Radioactive Iodine-Refractory Advanced Thyroid Carcinoma
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Concerns of Gonadal Dysfunction Following Radioactive Iodine (RAI131) Treatment for Thyroid Cancer
Cancer therapy & Oncology International Journal
Budget Impact and Incremental Survival Benefit of Using Lenvatinib as a Treatment for Radioactive Iodine Refractory Differentiated Thyroid Cancer in Russia
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
A Systematic Review of Lenvatinib and Sorafenib for Treating Progressive, Locally Advanced or Metastatic, Differentiated Thyroid Cancer After Treatment With Radioactive Iodine
BMC Cancer
Cancer Research
Oncology
Genetics
Renal Dysfunction in Patients With Radioactive Iodine-Refractory Thyroid Cancer Treated With Tyrosine Kinase Inhibitors
Medicine
Medicine
